SOFIA (Bulgaria), September 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev further increased his interest in the company through 21 transactions on the regulated market of the Bulgarian Stock Exchange on September 16.